Colorectal Cancer
📧 Sign up to get email alerts when something new happens for Colorectal Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-04-15Clinical Trial Update: Individualized Pneumoperitoneum Pressure in Colorectal Laparoscopic Surgery Versus Standard Therapy (IPPCollapse-II) [Phase 4]
A Phase 4 trial comparing individualized pneumoperitoneum pressure to standard therapy in colorectal laparoscopic surgery has been completed…
-
CLINICAL_TRIALS trial_result · 2020-04-09Clinical Trial Update: SarCNU in Treating Patients With Recurrent or Metastatic Colorectal Cancer [Phase 2]
Phase 2 trial update for SarCNU in recurrent or metastatic colorectal cancer has completed.
-
FDA approval · 2020-04-08FDA Approved: BRAFTOVI — Supplemental Application (Array BioPharma Inc.)
The FDA approved a supplemental application for BRAFTOVI (encorafenib) filed by Array BioPharma Inc., resulting in an updated indication/lab…
-
CLINICAL_TRIALS trial_result · 2020-04-08Clinical Trial Update: Skin Toxicity in Patients With Metastatic Colorectal Cancer Treated With Anti-EGFR and Chemotherapy (DERMIA) [Phase 2]
Phase 2 trial update investigating skin toxicity in metastatic colorectal cancer patients treated with anti-EGFR therapy plus chemotherapy (…
-
FDA approval · 2020-04-06FDA Approved: OXALIPLATIN — Supplemental Application (Winthrop U.S, a business of sanofi-aventis U.S. LLC)
The FDA approved a supplemental application for oxaliplatin submitted by Winthrop U.S., a business of sanofi-aventis U.S. LLC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-04-06Clinical Trial Update: Immediate Compared With Delayed Chemotherapy in Advanced Colorectal Cancer Without Signs or Symptoms of Disease [Phase 3]
Phase 3 trial comparing immediate versus delayed chemotherapy in advanced colorectal cancer without signs or symptoms of disease has complet…
-
CLINICAL_TRIALS trial_result · 2020-04-03Clinical Trial Update: Avelumab for MSI-H or POLE Mutated Metastatic Colorectal Cancer [Phase 2]
Phase 2 clinical trial update for avelumab in MSI-H or POLE-mutated metastatic colorectal cancer.
-
CLINICAL_TRIALS trial_result · 2020-04-03Clinical Trial Update: Cetuximab Plus Biweekly Capecitabine and Oxaliplatin in KRAS Wild Type Metastatic Colorectal Cancer [Phase 2]
Phase 2 trial evaluating cetuximab with biweekly capecitabine and oxaliplatin in KRAS wild-type metastatic colorectal cancer has completed; …
-
CLINICAL_TRIALS trial_result · 2020-03-31Clinical Trial Update: Erbitux MEtastatic Colorectal Cancer Strategy Study [Phase 3]
Phase 3 trial update for Erbitux in metastatic colorectal cancer has completed.
-
CLINICAL_TRIALS trial_result · 2020-03-31Clinical Trial Update: FOLFOXIRI With or Without Cetuximab as First-line Treatment of Patients With Non-resectable Liver - Only Metastatic Colorectal Cancer [Phase 2]
Phase 2 trial evaluating FOLFOXIRI with or without cetuximab as first-line treatment for non-resectable liver-only metastatic colorectal can…
-
CLINICAL_TRIALS trial_result · 2020-03-30Clinical Trial Update: G-CSF in Preventing Neutropenia During First-Line Treatment With Chemotherapy and Bevacizumab in Patients With Metastatic Colorectal Cancer [Phase 2]
Phase 2 clinical trial evaluating G-CSF to prevent neutropenia during first-line chemotherapy with bevacizumab in metastatic colorectal canc…
-
CLINICAL_TRIALS trial_result · 2020-03-30Clinical Trial Update: Combination Chemotherapy and Bevacizumab With or Without Bevacizumab Maintenance Therapy in Treating Patients With Metastatic Colorectal Cancer [Phase 2, Phase 3]
A study evaluating combination chemotherapy with bevacizumab, with or without maintenance bevacizumab, in metastatic colorectal cancer (Phas…
-
CLINICAL_TRIALS trial_result · 2020-03-25Clinical Trial Update: A Study Comparing the Efficacy and Safety of Vanucizumab and FOLFOX With Bevacizumab and FOLFOX in Participants With Untreated Metastatic Colorectal Cancer [Phase 2]
Phase 2 trial comparing vanucizumab+FOLFOX versus bevacizumab+FOLFOX in untreated metastatic colorectal cancer; study terminated with posted…
-
CLINICAL_TRIALS research · 2020-03-19Clinical Trial Update: Evidence-Based Colorectal Cancer Screening for the Uninsured [NA]
A completed clinical trial evaluating evidence-based colorectal cancer screening for uninsured individuals; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-03-18Clinical Trial Update: Radical Colorectal Resection and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Locally Advanced Colorectal Cancer [Phase 2]
Phase 2 clinical trial investigating radical colorectal resection with hyperthermic intraperitoneal chemotherapy (HIPEC) for locally advance…
-
CLINICAL_TRIALS trial_result · 2020-03-17Clinical Trial Update: Phase II Study of Minocycline for Reducing Symptom Burden in Colorectal Patients [Phase 2]
Phase II study evaluating minocycline to reduce symptom burden in colorectal cancer patients has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-03-16Clinical Trial Update: A Trial of SHR-1210 in Combination With AIN457 in Patients With MSS CRC（SHR-1210-AIN457） [Phase 1, Phase 2]
Clinical trial update for SHR-1210 in combination with AIN457 in patients with metastatic or microsatellite-stable colorectal cancer, spanni…
-
CLINICAL_TRIALS trial_result · 2020-03-16Clinical Trial Update: Panitumumab and Bortezomib for Patients With Advanced Colorectal Cancer [Phase 1, Phase 2]
A phase 1/2 trial evaluating panitumumab in combination with bortezomib in advanced colorectal cancer was terminated; results were posted.
-
CLINICAL_TRIALS trial_result · 2020-03-13Clinical Trial Update: Aspirin/Folate Prevention of Large Bowel Polyps [Phase 2, Phase 3]
Phase 2/3 trial update on aspirin/folate prevention for large bowel polyps in colorectal cancer/adenoma context.
-
CLINICAL_TRIALS trial_result · 2020-03-12Clinical Trial Update: Phase I / II Study of Enadenotucirev by Sub-acute Fractionated IV Dosing in Cancer Patients [Phase 1, Phase 2]
Phase I/II study of enadenotucirev given via sub-acute fractionated IV dosing in cancer patients (completed).
-
CLINICAL_TRIALS research · 2020-03-12Clinical Trial Update: Collaborative Care to Reduce Depression and Increase Cancer Screening Among Low-Income Urban Women [NA]
A completed clinical trial evaluating collaborative care to reduce depression and increase cancer screening among low-income urban women.
-
CLINICAL_TRIALS trial_result · 2020-03-10Clinical Trial Update: Study Comparing Different Dose Approaches of Induction Treatment of Regorafenib in MCRC [Phase 2]
Phase 2 trial comparing different induction-dose approaches of regorafenib in metastatic colorectal cancer has completed.
-
CLINICAL_TRIALS trial_result · 2020-03-06Clinical Trial Update: SOX Versus XELOX as Adjuvant Chemotherapy for Stage III Colorectal Cancer Patients [Phase 3]
Phase 3 trial comparing SOX vs XELOX as adjuvant chemotherapy in stage III colorectal cancer; status currently UNKNOWN.
-
CLINICAL_TRIALS trial_result · 2020-03-04Clinical Trial Update: Efficacy of Perioperative Duloxetine as a Part of Multimodal Analgesia in Laparoscopic Colorectal Cancer Surgery [Phase 2]
Phase 2 clinical trial exploring perioperative duloxetine as part of multimodal analgesia for laparoscopic colorectal cancer surgery.
-
CLINICAL_TRIALS trial_result · 2020-02-28Clinical Trial Update: Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With RAS Wild-Type Locally Advanced or Metastatic Colorectal Cancer That Cannot Be Removed by Surgery [Phase 2]
Phase 2 trial evaluating irinotecan and cetuximab with or without bevacizumab in RAS wild-type locally advanced or metastatic colorectal can…